124.55 9% 104.83 8% Investment in associated company 397.46 28% 483.96 36% Property, plant and equipment 644.04 46% 558.59 42% Biological assets – dairy cow 45.60 3% 44.28 3% Others 61.05 5% 61.09 4% Total

from change in fair value of biological assets 9.70 Million Baht. The main cause is the value of economic trees that was recorded in the consolidated financial statements as at 31 December 2016

entails relatively high risk, as KTMS represents a significant source of revenue and profit for FVC with continued growth prospects. While regulations relevant to the operation of the business may become

improvement. Other Transaction In Year 2018, the company recorded Baht 34.0 million from gain on changes in fair value less costs to sell biological asset, gain on sales deposits from land Baht 22.2 million and

cost to sale of biological assets. Financial Cost Financial cost in Quarter 2/2019 was Baht 8.5 Million decreased by Baht 1.3 Million or 13.1% from Q2/2018 mainly from bank loan repayment in 2018. Net

Transaction In Quarter 2/2018, the company recorded Baht 22.2 million from gain on sales of deposits for land, Baht 3.9 million from gain on changes in fair value less costs to sell biological asset and Baht

and internal control of subsidiaries improvement. Other Transaction In Quarter 3/2018, the company recorded Baht 4.0 million from gain on changes in fair value less costs to sell biological asset and

essential for economic development and sustainability. Applying science to Thailand?s resource abundance and biological diversity will bring about better quality of life and economic sustainable development

(149.9) (13.3) Other current assets 252.7 203.1 49.6 24.4 Property, plant and equipment 219.1 96.2 122.9 127.8 Equipment for lease 308.7 358.5 (49.8) (13.9) Biological assets 9.9 0.0 9.9 100.0 Other non

planned, the conglomerate enable to derive income from good prospects business. 12. Opinion of the Audit Committee and/or opinion of the director which is different from the opinion of the Board under